TY - JOUR
T1 - Analyses of short-term antagonistic evolution of Pseudomonas Aeruginosa strain PAO1 and phage KPP22 (Myoviridae family, PB1-like virus genus)
AU - Uchiyama, Jumpei
AU - Suzuki, Masato
AU - Nishifuji, Koji
AU - Kato, Shin ichiro
AU - Miyata, Reina
AU - Nasukawa, Tadahiro
AU - Yamaguchi, Kotoe
AU - Takemura-Uchiyama, Iyo
AU - Ujihara, Takako
AU - Shimakura, Hidekatsu
AU - Murakami, Hironobu
AU - Okamoto, Noriaki
AU - Sakaguchi, Yoshihiko
AU - Shibayama, Keigo
AU - Sakaguchi, Masahiro
AU - Matsuzaki, Shigenobu
N1 - Funding Information:
This work, including the efforts of Jumpei Uchiyama, was funded by Japan Society for the Promotion of Science (JSPS) (22890129, 24791025, and 15K19095).
Publisher Copyright:
© 2016, American Society for Microbiology.
PY - 2016
Y1 - 2016
N2 - Pseudomonas aeruginosa causes serious intractable infections in humans and animals. Bacteriophage (phage) therapy has been applied to treat P. aeruginosa infections, and phages belonging to the PB1-like virus genus in the Myoviridae family have been used as therapeutic phages. To achieve safer and more effective phage therapy, the use of preadapted phages is proposed. To understand in detail such phage preadaptation, the short-term antagonistic evolution of bacteria and phages should be studied. In this study, the short-term antagonistic evolution of bacteria and PB1-like phage was examined by studying phage-resistant clones of P. aeruginosa strain PAO1 and mutant PB1-like phages that had recovered their infectivity. First, phage KPP22 was isolated and characterized; it was classified as belonging to the PB1-like virus genus in the Myoviridae family. Subsequently, three KPP22-resistant PAO1 clones and three KPP22 mutant phages capable of infecting these clones were isolated in three sets of in vitro experiments. It was shown that the bacterial resistance to phage KPP22 was caused by significant decreases in phage adsorption and that the improved infectivity of KPP22 mutant phages was caused by significant increases in phage adsorption. The KPP22-resistant PAO1 clones and the KPP22 mutant phages were then analyzed genetically. All three KPP22-resistant PAO1 clones, which were deficient for the O5 antigen, had a common nonsense mutation in the wzy gene. All the KPP22 mutant phage genomes showed the same four missense mutations in the open reading frames orf060, orf065, and orf086. The information obtained in this study should be useful for further development of safe and efficient phage therapy.
AB - Pseudomonas aeruginosa causes serious intractable infections in humans and animals. Bacteriophage (phage) therapy has been applied to treat P. aeruginosa infections, and phages belonging to the PB1-like virus genus in the Myoviridae family have been used as therapeutic phages. To achieve safer and more effective phage therapy, the use of preadapted phages is proposed. To understand in detail such phage preadaptation, the short-term antagonistic evolution of bacteria and phages should be studied. In this study, the short-term antagonistic evolution of bacteria and PB1-like phage was examined by studying phage-resistant clones of P. aeruginosa strain PAO1 and mutant PB1-like phages that had recovered their infectivity. First, phage KPP22 was isolated and characterized; it was classified as belonging to the PB1-like virus genus in the Myoviridae family. Subsequently, three KPP22-resistant PAO1 clones and three KPP22 mutant phages capable of infecting these clones were isolated in three sets of in vitro experiments. It was shown that the bacterial resistance to phage KPP22 was caused by significant decreases in phage adsorption and that the improved infectivity of KPP22 mutant phages was caused by significant increases in phage adsorption. The KPP22-resistant PAO1 clones and the KPP22 mutant phages were then analyzed genetically. All three KPP22-resistant PAO1 clones, which were deficient for the O5 antigen, had a common nonsense mutation in the wzy gene. All the KPP22 mutant phage genomes showed the same four missense mutations in the open reading frames orf060, orf065, and orf086. The information obtained in this study should be useful for further development of safe and efficient phage therapy.
UR - http://www.scopus.com/inward/record.url?scp=84979895635&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84979895635&partnerID=8YFLogxK
U2 - 10.1128/AEM.00090-16
DO - 10.1128/AEM.00090-16
M3 - Article
C2 - 27208109
AN - SCOPUS:84979895635
SN - 0099-2240
VL - 82
SP - 4482
EP - 4491
JO - Applied and environmental microbiology
JF - Applied and environmental microbiology
IS - 15
ER -